Patrick Michael Jedlowski

11PUBLICATIONS
4CO-AUTHORS
Nanotoxicology, health and safetyAerodynamics (excl. hypersonic aerodynamics)AutoimmunityInnate immunityChemical engineering not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 27, 2025
Vismodegib and Sonidegib Are Associated With an Elevated Reporting Odds of Squamous Cell Carcinoma; a Comparative Pharmacovigilance Study of the FDA Adverse Events Reporting System (FAERS).

Patrick Jedlowski, Alexander Rose, Jason DuPont

|Dec 12, 2023
Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis.

Patrick M Jedlowski, Michelle Anthony

|Dec 10, 2023
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.

Patrick M Jedlowski, Jason P DuPont

|Nov 16, 2023
Annular plaques and nodules at vaccination sites in an infant.

Patrick M Jedlowski, Tracy L Davis, Sierra C Wolter

|Dec 10, 2022
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Patrick Michael Jedlowski

|Mar 22, 2022
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system.

Patrick Michael Jedlowski, Mahdieh Fazel Jedlowski

Pageof 2

Frequent Collaborators

1 joint publications

Alexander Rose

1 joint publications

Maryam T Fazel

1 joint publications

Mahdieh Fazel

1 joint publications

So Yeon Paek